MoneyWorks4Me

Natural Capsules - Quaterly Results

13 Feb 2023 Evaluate
The revenue zoomed 20.98% to Rs. 455.00 millions for the quarter ended December 2022 as compared to Rs. 376.10 millions during the corresponding quarter last year.The company has announced a 27.12% increase in its profits to Rs . 52.50  millions for the  quarter ended December 2022 compared to Rs. 41.30 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended December 2022 rose to 97.10 millions as compared to 77.60 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 455.00 376.10 20.98 1347.50 935.20 44.09 1350.70 795.10 69.88
Other Income 0.10 0.60 -83.33 2.60 2.00 30.00 9.30 7.30 27.40
PBIDT 97.10 77.60 25.13 288.10 175.00 64.63 264.30 116.90 126.09
Interest 9.50 5.70 66.67 22.90 12.90 77.52 19.60 3.70 429.73
PBDT 87.60 71.90 21.84 265.20 162.10 63.60 244.70 135.00 81.26
Depreciation 17.40 12.50 39.20 53.30 36.40 46.43 50.40 43.10 16.94
PBT 70.20 59.40 18.18 211.90 125.70 68.58 194.30 91.90 111.43
TAX 17.70 18.10 -2.21 53.60 37.10 44.47 54.70 22.40 144.20
Deferred Tax 1.00 1.60 -37.50 4.60 4.60 0.00 7.30 0.20 3550.00
PAT 52.50 41.30 27.12 158.30 88.60 78.67 139.60 69.50 100.86
Equity 92.40 70.10 31.81 92.40 70.10 31.81 70.10 62.30 12.52
PBIDTM(%) 21.34 20.63 3.43 21.38 18.71 14.26 19.57 14.70 33.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..